Jim Brown CEO stated the following:
"The FDA has
Jim Brown CEO stated the following:
"The FDA has confirmed that a single pivotal trial would be sufficient to support an NDA filing in AH. They also clearly recognize the unmet need in AH and the strong results of larsucosterol and our Phase IIb trial AHFIRM."
"Under this distinctive designation in July, we had a very productive and positive Type B meeting with the FDA to discuss our trial design. In fact, this meeting was the most productive interaction I've had with the FDA in my 30-plus-year career in drug development. We are awaiting the written minutes from this meeting and look forward to sharing more details about our proposed protocol in the near future once we receive those minutes."
Durect Corp. (DRRX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Yosvany Rodriguez Celebrated for Leadership in Business Prominently featured as an influential leader, Yosvany Rodriguez is acknowledged for his exceptional contributions to strategic business leadership and innovation. His reputation is built on a solid foundation of experience and dedication, making him a respected figure in the business community. Key Contributions and...
Continue Reading
Addressing Capacity Concerns in the Magnet Industry USA Rare Earth Inc. (NASDAQ: USAR) is currently grappling with significant challenges in meeting the increasing demand for magnets. Rob Steele, the CFO of the company, openly acknowledged these hurdles during a recent earnings call, emphasizing, "We don't have enough capacity to supply demand for 2026… our demand curve...
Continue Reading
Smartee and Shanghai Ninth People's Hospital Earn Title at Innovation Awards Smartee Denti-Technology, an innovative leader in orthodontic solutions, is thrilled to announce its recent achievement alongside Shanghai Ninth People's Hospital. Together, they have been awarded the First Prize at a notable scientific awards ceremony, highlighting their collaboration in...
Continue Reading
Overview of Recent Asian Stock Market Trends Recently, stock markets across Asia have shown a generally positive trend, driven by optimism surrounding lower interest rates announced by several central banks. However, the Australian markets have faced a decline, primarily due to substantial losses reported by key retailers dealing with legal challenges. Investors are...
Continue Reading
ibex's Generous Contribution to Veterans' Welfare ibex (NASDAQ: IBEX), a prominent global provider of business process outsourcing (BPO) and AI-driven customer engagement solutions, is elated to announce a donation of $25,000 to the Wounded Warrior Project (WWP) under its philanthropic initiative, ibex Cares. This support is a crucial contribution to WWP’s mission,...
Continue Reading
